Journal
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
Volume 13, Issue 9, Pages 4627-4630Publisher
ASIAN PACIFIC ORGANIZATION CANCER PREVENTION
DOI: 10.7314/APJCP.2012.13.9.4627
Keywords
Pancreatic cancer; MTHFR; gene polymorphism; meta-analysis
Categories
Ask authors/readers for more resources
Purpose: Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms have been reported to be associated with pancreatic cancer, but the published studies have yielded inconsistent results. This study assessed the relationship between MTHFR gene polymorphisms and the risk for pancreatic cancer using a meta-analysis approach. Methods: A search of Google scholar, PubMed, Cochrane Library and CNKI databases before April 2012 was performed, and then associations of the MTHFR polymorphisms with pancreatic cancer risk were summarized. The association was assessed by odds ratios (ORs) with 95% confidence intervals (CIs). Publication bias was also calculated. Results: Four relative studies on MTHFR gene polymorphisms (C667T and A1298C) were included in this meta-analysis. Overall, C667T (TT vs. CC: OR=1.61,95% CI=0.78-3.34; TT vs. CT: OR=1.41,95% CI=0.88-2.25; Dominant model: OR=0.68,95% CI=0.40-1.17; Recessive model: OR=0.82,95% CI=0.52-1.30) and A1298C (CC vs. AA: OR=1.01,95% CI=0.47-2.17; CC vs. AC: OR=0.99,95% CI=0.46-2.14; Dominant model: OR=1.01, 95% CI=0.47-2.20; Recessive model: OR=1.01,95% CI=0.80-1.26) did not increase pancreatic cancer risk. Conclusions: This meta-analysis indicated that MTHFR polymorphisms (C667T and A1298C) are not associated with pancreatic cancer risk.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available